glp-1 agonist drugs Receptor Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1 drugs promise wider health

Distribution Channel Insights The retail pharmacies segment dominated the market with the largest share in 2025

[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Li L., Shen J., Bala M.M., Busse J.W., Ebrahim S., Vandvik P.O., Rios L.P., Malaga G., Wong E., Sohani Z., et al

Feingold KR, Anawalt B, Blackman MR, editors

and international guidelines are rapidly evolving to address the risks associated with GLP-1 use

21,22 However, no association was found between pancreatitis and use of GLP-1RAs in the randomised controlled cardiovascular outcome trials, meta-analyses and systematic reviews

10.1111/jne.12643 5 GierB.MatveyenkoA